Clinical trial
Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV…
NCT00004209 · Cancer Research UK, Other · Unknown status
Key facts
| NCT number | NCT00004209 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer |
| Official title | A Randomized Study of MVP 3 Versus 6 Cycles in Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Cancer Research UK, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, mitomycin C, vinblastine sulfate |
| Start date | May 1, 1998 |
| First posted | Sep 16, 2004 |
| Last update posted | Aug 7, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: